1. Home
  2. BAFN vs CSBR Comparison

BAFN vs CSBR Comparison

Compare BAFN & CSBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BAFN
  • CSBR
  • Stock Information
  • Founded
  • BAFN 1999
  • CSBR 1985
  • Country
  • BAFN United States
  • CSBR United States
  • Employees
  • BAFN N/A
  • CSBR N/A
  • Industry
  • BAFN Savings Institutions
  • CSBR Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • BAFN Finance
  • CSBR Health Care
  • Exchange
  • BAFN Nasdaq
  • CSBR Nasdaq
  • Market Cap
  • BAFN 55.9M
  • CSBR 65.9M
  • IPO Year
  • BAFN N/A
  • CSBR 1986
  • Fundamental
  • Price
  • BAFN $12.98
  • CSBR $4.44
  • Analyst Decision
  • BAFN
  • CSBR Strong Buy
  • Analyst Count
  • BAFN 0
  • CSBR 1
  • Target Price
  • BAFN N/A
  • CSBR $6.00
  • AVG Volume (30 Days)
  • BAFN 8.7K
  • CSBR 11.4K
  • Earning Date
  • BAFN 10-24-2024
  • CSBR 12-10-2024
  • Dividend Yield
  • BAFN 2.37%
  • CSBR N/A
  • EPS Growth
  • BAFN N/A
  • CSBR N/A
  • EPS
  • BAFN 0.73
  • CSBR N/A
  • Revenue
  • BAFN $76,217,000.00
  • CSBR $51,655,000.00
  • Revenue This Year
  • BAFN N/A
  • CSBR $9.27
  • Revenue Next Year
  • BAFN N/A
  • CSBR $9.76
  • P/E Ratio
  • BAFN $18.08
  • CSBR N/A
  • Revenue Growth
  • BAFN 7.06
  • CSBR N/A
  • 52 Week Low
  • BAFN $10.15
  • CSBR $3.60
  • 52 Week High
  • BAFN $15.05
  • CSBR $7.13
  • Technical
  • Relative Strength Index (RSI)
  • BAFN 40.68
  • CSBR 51.57
  • Support Level
  • BAFN $13.46
  • CSBR $4.26
  • Resistance Level
  • BAFN $15.05
  • CSBR $4.70
  • Average True Range (ATR)
  • BAFN 0.57
  • CSBR 0.26
  • MACD
  • BAFN -0.05
  • CSBR 0.02
  • Stochastic Oscillator
  • BAFN 32.41
  • CSBR 64.86

About BAFN BayFirst Financial Corp.

BayFirst Financial Corp is a one bank holding company, it generates its revenue from interest on loans and the gain-on-sale income derived from the sale of loans into the secondary market. The company serves a broad spectrum of individuals, families, and small businesses, supported by national business lines in residential and SBA lending and technology platforms. The primary source of funding for its loans is deposits. BayFirst measures performance through net interest income after provision for loan losses, return on average assets, and return on average common equity, while maintaining appropriate regulatory leverage and risk-based capital ratios.

About CSBR Champions Oncology Inc.

Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.

Share on Social Networks: